Business Of Biotech

Updated: 20 Oct 2025 • 277 episodes
www.bioprocessonline.com/solution/the-business-of-biotech-podcast

The Business of Biotech is the pod dedicated to leaders of emerging biopharma firms. SUBSCRIBE to our new newsletter at www.bioprocessonline.com/bob. We bring you insight into organizational, finance and funding, HR, clinical, manufacturing, regulatory, and commercial challenges you’ll face as you navigate your company from an idea to success in the clinic and beyond. Each episode features guest commentary and best practices from accomplished founders and biopharma industry luminaries. The Business of Biotech is produced by Life Science Connect.

Show episodes

We love to hear from our listeners. Send us a message. On this week"s episode of the Business of Biotech -- part three in a four part series recorded in-person at Catalyst Pharmaceuticals" Miami headquarters -- Anthony Japour, M.D., CEO at iTolerance, talks about his work as a physician treating infectious diseases, hi

33 min
00:00
33:34
No file found

We love to hear from our listeners. Send us a message. In this week"s episode of the Business of Biotech -- part two in a four-part series recorded in-person at Catalyst Pharmaceuticals" Miami headquarters -- we"re speaking with Daniel Teper, an entrepreneur and most recently, founder and CEO at NAYA Therapeutics. Base

33 min
00:00
33:08
No file found

We love to hear from our listeners. Send us a message. The Business of Biotech is on location in Miami this week! For the first episode in this four-part series on the biotech scene in South Florida, Raquel Cabo, Founder and President of the Miami Biotech Collective, talks about her experiences as a member of the found

34 min
00:00
34:58
No file found

We love to hear from our listeners. Send us a message. On this week"s episode of the Business of Biotech, Rob Abbott, CEO of ISPOR, explains how startup and early-stage clinical drug development companies benefit from conducting health economics and outcomes research (HEOR), and not just with patients and commercial pa

57 min
00:00
57:58
No file found

We love to hear from our listeners. Send us a message. On this week"s episode, Joel Latham, President and CEO at Incannex Healthcare, talks about developing cannabinoid and psychedelic combination therapies for conditions as diverse as sleep apnea, rheumatoid arthritis, and generalized anxiety disorder. Joel walks thro

57 min
00:00
57:27
No file found

We love to hear from our listeners. Send us a message. On this week"s episode, Lyle Small, Founder and CEO at Lahjavida, a dye drug conjugate start-up, talks about creating the famous color-changing technology that turned the mountains blue on cold Coors Light beer cans, to launching a dye-drug conjugate startup develo

58 min
00:00
58:25
No file found